C
CYTK icon

Covestor’s Cytokinetics CYTK Stock Holding History

Covestor’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85K Sell
998
-367
-27% -$26.4K 0.05% 452
2026
Q1 		$90K Sell
1,365
-606
-31% -$38.5K 0.06% 340
2025
Q4 		$125K Sell
1,971
-340
-15% -$21.1K 0.07% 442
2025
Q3 		$128K Buy
2,311
+1,600
+225% +$65.9K 0.07% 431
2025
Q2 		$24K Sell
711
-1,203
-63% -$41.8K 0.01% 1181
2025
Q1 		$77K Buy
1,914
+1,748
+1,053% +$80.3K 0.05% 637
2024
Q4 		$8K Sell
166
-525
-76% -$27.3K 0.01% 1629
2024
Q3 		$37K Sell
691
-1,204
-64% -$67.1K 0.02% 978
2024
Q2 		$102K Buy
1,895
+1,730
+1,048% +$104K 0.07% 473
2024
Q1 		$12K Sell
165
-338
-67% -$26.1K 0.01% 1434
2023
Q4 		$42K Buy
503
+300
+148% +$10.9K 0.03% 924
2023
Q3 		$6K Buy
203
+31
+18% +$1.03K ﹤0.01% 1668
2023
Q2 		$6K Sell
172
-1
-0.6% -$37 ﹤0.01% 1672
2023
Q1 		$6K Hold
173
– – 0.01% 1504
2022
Q4 		$8K Buy
173
+165
+2,063% +$7.1K 0.01% 1412
2022
Q3 		$0 Sell
8
-1
-11% -$48 ﹤0.01% 2091
2022
Q2 		$0 Sell
9
-9
-50% -$362 ﹤0.01% 1998
2022
Q1 		$1K Buy
18
+1
+6% +$36 ﹤0.01% 1773
2021
Q4 		$1K Buy
+17
New +$656 ﹤0.01% 1707

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Covestor's CYTK Position: Q2 2026 in Review

Covestor reduced its Cytokinetics (CYTK) stake by 27% in Q2 2026, selling an estimated $26.4K and leaving 998 shares worth $85K. The position accounts for 0.05% of the portfolio, ranked #452.

Covestor first reported a position in CYTK in Q4 2021 and has held it in 19 quarters since. The position peaked at $128K in Q3 2025. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Covestor held 998 shares of Cytokinetics worth $85K as of Q2 2026.
  • Covestor sold 367 Cytokinetics shares in Q2 2026, an estimated $26.4K.
  • Cytokinetics made up 0.05% of Covestor's portfolio in Q2 2026, its #452 holding.
  • Covestor first reported a position in Cytokinetics in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Cytokinetics position peaked at $128K in Q3 2025.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.